돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1451894생성일: 2026년 10월 25일

Potassium Iodide → 3-[1-(4-Chloro-6,7-dimethoxy-1-phthalazinyl)-4-piperidinyl]-1,2,3,4-tetrahydro-1,6-dimethyl-2,4-dioxo-quinazoline

https://huagongshe.com/reaction/1451894

반응식

참여 물질

역할이름HCID투입량
반응물Potassium IodideHCID 4875—
반응물1,4-Dichloro-6,7-dimethoxyphthalazineHCID 13505323—
반응물1,2,3,4-Tetrahydro-1,6-dimethyl-2,4-dioxo-3-(4-piperidinyl)quinazoline hydrobromideHCID 21851222—
생성물3-[1-(4-Chloro-6,7-dimethoxy-1-phthalazinyl)-4-piperidinyl]-1,2,3,4-tetrahydro-1,6-dimethyl-2,4-dioxo-quinazolineHCID 2292346149%

반응 단계

The procedure similar to that described in Example 15 was repeated, except that 354.0 mg (1.0 mmol) of 1,2,3,4-tetrahydro-1,6-dimethyl-2,4-dioxo-3-(4-piperidinyl)quinazoline hydrobromide (Compound v) obtained in Example 41 was used, 1,4-dichloro-6,7-dimethoxyphthalazine was used in place of 4-chloro-6,7-dimethoxyquinazoline, and a catalytic amount of potassium iodide was added. As a result, 243.7 mg (yield: 49%) of Compound 76 was obtained as white crystals.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US05605900
출처 데이터셋uspto-grants-1997_02
ORD IDord-3020757cc2c048f8829d23a2a3486f70
출처 메모uspto-grants-1997_02